- Info
- Significant Ownership
- Insider Ownership
Significant Ownership of Adimab, LLC
- Signature - Title
- /s/ Philip Chase - Philip Chase, Chief Executive Officer
- Location
- Lebanon, NH
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Adimab, LLC.
Follow Filing Activity
Follow Adimab, LLC and return when a new Schedule 13D/G filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Continue schedule research
Related filing hubs for this reporting manager, useful for reinforcing crawl paths across the schedule cluster.
Significant Ownership of Adimab, LLC
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| IVVD | Invivyd, Inc. | Common Stock, $0.0001 par value per share | 7.3% | $47,210,856 | -$448,106 | 20,262,170 | -0.94% | Adimab, LLC | 23 Dec 2025 |
Schedules 13D/G Reported by Adimab, LLC:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.